Trazodone extended release for major depressive disorder — Current Psychiatry Online

Links shared publicly online about this topic.

  • 637
    total visits

Trazodone extended release for major depressive disorder — Current Psychiatry Online

currentpsychiatry.com

Trazodone extended release for major depressive disorder — Current Psychiatry Online

View full resource at currentpsychiatry.com

Tags: Pain Medication, Depression, Antidepressant, Major Depression, Disease and Condition, Desyrel, Psychiatry

  • Share

Most Recently Shared on December 22, 2010 at 1:21 pm By:

currentpsych Current Psychiatry

Out of the Pipeline: Trazodone extended release (Oleptro) for major depressive disorder: What the evidence says http://bit.ly/gXtmXq

1 year ago...

Psychiatry Article | Depressive Disorder

mdlinx.com — “Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized studyView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on December 29, 2010 at 1:04 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depr... http://bit.ly/gm7F0d #PSY

1 year ago...

OLEPTRO - New Product Releases - MPR

empr.com — “Major depressive disorder.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on August 20, 2010 at 1:05 pm By:

eMPR MPR Medical Publisher

MPR News: OLEPTRO: Trazodone HCl 150mg, 300mg; scored ext-rel tabs. http://bit.ly/bC5jad

2 years ago...

Angelini Labopharm Announces The U.S. Launch Of OLEPTRO™ For The Treatment Of Major Depressive Disorder In Adults

medicalnewstoday.com — “Angelini Labopharm announced that OLEPTRO™ (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, is now commercially available iView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on August 16, 2010 at 12:35 pm By:

PeterBrownPsy Peter H Brown Psychologist and Doctor

Angelini Labopharm Announces The U.S. Launch Of OLEPTRO™ For The Treatment Of Major Depressive Dis.. http://mnt.to/f/3HpG #depression

2 years ago...

Oleptro available for major depressive disorder - MPR

empr.com — “Labopharm and Angelini announced the launch of Oleptro (trazodone HCl extended-release tablets) for the treatment of major depressive disorder (MDD) in adults.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on August 10, 2010 at 3:33 pm By:

eMPR MPR Medical Publisher

MPR News: Oleptro available for major depressive disorder: Labopharm and Angelini announced the launch of Oleptro ... http://bit.ly/9xoFSv

2 years ago...

FDA Approves First Generic Effexor Extended Release Capsules To Treat Major Depressive Disorder | Psydir News

news.psydir.com — “On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder. Venlafaxine hydrochloride extended-release capsules in 37.5 milligram, 75 milligram and 150 milligram strengths have been approved to be manufactured by TEVA Pharmaceuticals, North Wales, Pa...View full resource at news.psydir.com

  • View Related
  • Share

Most Recently Shared on June 30, 2010 at 2:07 pm By:

psydir PsyDir News Health News

FDA Approves First Generic Effexor Extended Release Capsules To Treat Major Depressive… http://goo.gl/fb/mLr0y

2 years ago...

US FDA Approves SEROQUEL XR(R) For Add-On Treatment Of Major Depressive Disorder

medicalnewstoday.com — “Astrazeneca (nyse: azn) announced that the us food and drug administration (fda) has approved once-daily seroquel xr® (quetiapine fumarate) extended release tablets as adjunctive (add-on) treView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 5, 2009 at 12:19 pm By:

mnt_depression MNT Depression News Health News

US FDA Approves SEROQUEL XR(R) For Add-On Treatment Of Major Depressive Disorder: AstraZeneca (NYSE: AZN) annou.. http://bit.ly/7L8u0I

2 years ago...

Advertisement